nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—GRIA2—amyotrophic lateral sclerosis	0.677	1	CbGaD
Secobarbital—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.107	1	CbGbCtD
Secobarbital—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.00894	0.111	CcSEcCtD
Secobarbital—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.00812	0.101	CcSEcCtD
Secobarbital—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00524	0.0653	CcSEcCtD
Secobarbital—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00396	0.0493	CcSEcCtD
Secobarbital—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00393	0.0489	CcSEcCtD
Secobarbital—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00364	0.0453	CcSEcCtD
Secobarbital—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00339	0.0422	CcSEcCtD
Secobarbital—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00333	0.0415	CcSEcCtD
Secobarbital—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00331	0.0412	CcSEcCtD
Secobarbital—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00322	0.04	CcSEcCtD
Secobarbital—CHRNA4—peripheral nervous system—amyotrophic lateral sclerosis	0.00301	0.047	CbGeAlD
Secobarbital—GRIK2—nerve—amyotrophic lateral sclerosis	0.00292	0.0456	CbGeAlD
Secobarbital—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00289	0.036	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00256	0.0319	CcSEcCtD
Secobarbital—GRIA2—hindbrain—amyotrophic lateral sclerosis	0.00242	0.0378	CbGeAlD
Secobarbital—CHRNA4—nerve—amyotrophic lateral sclerosis	0.00235	0.0366	CbGeAlD
Secobarbital—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.00234	0.0365	CbGeAlD
Secobarbital—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00227	0.0283	CcSEcCtD
Secobarbital—GRIK2—hindbrain—amyotrophic lateral sclerosis	0.00219	0.0341	CbGeAlD
Secobarbital—CHRNA4—hindbrain—amyotrophic lateral sclerosis	0.00176	0.0274	CbGeAlD
Secobarbital—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00172	0.0269	CbGeAlD
Secobarbital—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.0017	0.0212	CcSEcCtD
Secobarbital—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00166	0.0207	CcSEcCtD
Secobarbital—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00158	0.0245	CbGeAlD
Secobarbital—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00152	0.0237	CbGeAlD
Secobarbital—GRIA2—embryo—amyotrophic lateral sclerosis	0.00152	0.0236	CbGeAlD
Secobarbital—Tension—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0178	CcSEcCtD
Secobarbital—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0176	CcSEcCtD
Secobarbital—GRIA2—brainstem—amyotrophic lateral sclerosis	0.00139	0.0216	CbGeAlD
Secobarbital—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00134	0.0209	CbGeAlD
Secobarbital—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0167	CcSEcCtD
Secobarbital—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0166	CcSEcCtD
Secobarbital—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0163	CcSEcCtD
Secobarbital—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0159	CcSEcCtD
Secobarbital—GRIK2—brainstem—amyotrophic lateral sclerosis	0.00125	0.0196	CbGeAlD
Secobarbital—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00124	0.0154	CcSEcCtD
Secobarbital—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0012	0.0149	CcSEcCtD
Secobarbital—Shock—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0146	CcSEcCtD
Secobarbital—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00111	0.0138	CcSEcCtD
Secobarbital—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0131	CcSEcCtD
Secobarbital—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0126	CcSEcCtD
Secobarbital—CHRNA4—brainstem—amyotrophic lateral sclerosis	0.00101	0.0157	CbGeAlD
Secobarbital—GABRB2—brainstem—amyotrophic lateral sclerosis	0.000988	0.0154	CbGeAlD
Secobarbital—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000979	0.0122	CcSEcCtD
Secobarbital—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000939	0.0117	CcSEcCtD
Secobarbital—Butabarbital—GRIA2—amyotrophic lateral sclerosis	0.000937	0.133	CrCbGaD
Secobarbital—GABRA2—brainstem—amyotrophic lateral sclerosis	0.000903	0.0141	CbGeAlD
Secobarbital—Butethal—GRIA2—amyotrophic lateral sclerosis	0.000887	0.126	CrCbGaD
Secobarbital—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000875	0.0109	CcSEcCtD
Secobarbital—GRIK2—medulla oblongata—amyotrophic lateral sclerosis	0.000875	0.0136	CbGeAlD
Secobarbital—GABRA1—brainstem—amyotrophic lateral sclerosis	0.000872	0.0136	CbGeAlD
Secobarbital—Butalbital—GRIA2—amyotrophic lateral sclerosis	0.000865	0.123	CrCbGaD
Secobarbital—GRIA2—spinal cord—amyotrophic lateral sclerosis	0.000864	0.0135	CbGeAlD
Secobarbital—Aprobarbital—GRIA2—amyotrophic lateral sclerosis	0.000854	0.121	CrCbGaD
Secobarbital—Thiopental—GRIA2—amyotrophic lateral sclerosis	0.000835	0.118	CrCbGaD
Secobarbital—Amobarbital—GRIA2—amyotrophic lateral sclerosis	0.000825	0.117	CrCbGaD
Secobarbital—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000786	0.00978	CcSEcCtD
Secobarbital—GRIK2—spinal cord—amyotrophic lateral sclerosis	0.00078	0.0122	CbGeAlD
Secobarbital—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000755	0.0094	CcSEcCtD
Secobarbital—Rash—Riluzole—amyotrophic lateral sclerosis	0.000749	0.00933	CcSEcCtD
Secobarbital—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000749	0.00932	CcSEcCtD
Secobarbital—Headache—Riluzole—amyotrophic lateral sclerosis	0.000744	0.00927	CcSEcCtD
Secobarbital—GRIA2—nervous system—amyotrophic lateral sclerosis	0.000728	0.0113	CbGeAlD
Secobarbital—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000706	0.00879	CcSEcCtD
Secobarbital—GABRA6—nervous system—amyotrophic lateral sclerosis	0.000703	0.011	CbGeAlD
Secobarbital—GRIA2—central nervous system—amyotrophic lateral sclerosis	0.000701	0.0109	CbGeAlD
Secobarbital—Pentobarbital—GRIA2—amyotrophic lateral sclerosis	0.000693	0.0983	CrCbGaD
Secobarbital—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.000689	0.0107	CbGeAlD
Secobarbital—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.000689	0.0107	CbGeAlD
Secobarbital—GRIA2—cerebellum—amyotrophic lateral sclerosis	0.000685	0.0107	CbGeAlD
Secobarbital—GABRA5—nervous system—amyotrophic lateral sclerosis	0.000682	0.0106	CbGeAlD
Secobarbital—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.000677	0.0105	CbGeAlD
Secobarbital—CHRFAM7A—nervous system—amyotrophic lateral sclerosis	0.000663	0.0103	CbGeAlD
Secobarbital—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.000662	0.0103	CbGeAlD
Secobarbital—GRIK2—nervous system—amyotrophic lateral sclerosis	0.000658	0.0102	CbGeAlD
Secobarbital—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.000657	0.0102	CbGeAlD
Secobarbital—CHRFAM7A—central nervous system—amyotrophic lateral sclerosis	0.000638	0.00995	CbGeAlD
Secobarbital—Talbutal—GRIA2—amyotrophic lateral sclerosis	0.000637	0.0903	CrCbGaD
Secobarbital—GABRA3—nervous system—amyotrophic lateral sclerosis	0.000635	0.0099	CbGeAlD
Secobarbital—GRIK2—central nervous system—amyotrophic lateral sclerosis	0.000633	0.00986	CbGeAlD
Secobarbital—CHRNA4—spinal cord—amyotrophic lateral sclerosis	0.000627	0.00977	CbGeAlD
Secobarbital—GABRA4—nervous system—amyotrophic lateral sclerosis	0.000619	0.00964	CbGeAlD
Secobarbital—GRIK2—cerebellum—amyotrophic lateral sclerosis	0.000619	0.00964	CbGeAlD
Secobarbital—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.000614	0.00957	CbGeAlD
Secobarbital—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.000614	0.00957	CbGeAlD
Secobarbital—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.000611	0.00953	CbGeAlD
Secobarbital—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.000608	0.00948	CbGeAlD
Secobarbital—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.000596	0.00928	CbGeAlD
Secobarbital—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.000582	0.00907	CbGeAlD
Secobarbital—GRIA2—brain—amyotrophic lateral sclerosis	0.000556	0.00867	CbGeAlD
Secobarbital—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.000542	0.00845	CbGeAlD
Secobarbital—GABRA6—brain—amyotrophic lateral sclerosis	0.000537	0.00838	CbGeAlD
Secobarbital—CHRNA7—nervous system—amyotrophic lateral sclerosis	0.000536	0.00835	CbGeAlD
Secobarbital—CHRNA4—nervous system—amyotrophic lateral sclerosis	0.000528	0.00823	CbGeAlD
Secobarbital—GABRA5—brain—amyotrophic lateral sclerosis	0.000521	0.00812	CbGeAlD
Secobarbital—Phenobarbital—GRIA2—amyotrophic lateral sclerosis	0.000519	0.0736	CrCbGaD
Secobarbital—GABRG2—nervous system—amyotrophic lateral sclerosis	0.000518	0.00807	CbGeAlD
Secobarbital—GABRB2—nervous system—amyotrophic lateral sclerosis	0.000518	0.00807	CbGeAlD
Secobarbital—CHRNA7—central nervous system—amyotrophic lateral sclerosis	0.000516	0.00804	CbGeAlD
Secobarbital—CHRNA4—central nervous system—amyotrophic lateral sclerosis	0.000509	0.00793	CbGeAlD
Secobarbital—CHRFAM7A—brain—amyotrophic lateral sclerosis	0.000507	0.0079	CbGeAlD
Secobarbital—GRIK2—brain—amyotrophic lateral sclerosis	0.000503	0.00783	CbGeAlD
Secobarbital—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.000498	0.00777	CbGeAlD
Secobarbital—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.000498	0.00777	CbGeAlD
Secobarbital—CHRNA4—cerebellum—amyotrophic lateral sclerosis	0.000497	0.00775	CbGeAlD
Secobarbital—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.000487	0.00759	CbGeAlD
Secobarbital—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.000487	0.00759	CbGeAlD
Secobarbital—GABRA3—brain—amyotrophic lateral sclerosis	0.000485	0.00756	CbGeAlD
Secobarbital—GABRA4—brain—amyotrophic lateral sclerosis	0.000473	0.00737	CbGeAlD
Secobarbital—GABRA2—nervous system—amyotrophic lateral sclerosis	0.000473	0.00737	CbGeAlD
Secobarbital—GABRA1—nervous system—amyotrophic lateral sclerosis	0.000457	0.00712	CbGeAlD
Secobarbital—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.000455	0.0071	CbGeAlD
Secobarbital—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.000445	0.00694	CbGeAlD
Secobarbital—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00044	0.00686	CbGeAlD
Secobarbital—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00043	0.0067	CbGeAlD
Secobarbital—CHRNA7—brain—amyotrophic lateral sclerosis	0.000409	0.00638	CbGeAlD
Secobarbital—CHRNA4—brain—amyotrophic lateral sclerosis	0.000404	0.00629	CbGeAlD
Secobarbital—GABRG2—brain—amyotrophic lateral sclerosis	0.000396	0.00617	CbGeAlD
Secobarbital—GABRB2—brain—amyotrophic lateral sclerosis	0.000396	0.00617	CbGeAlD
Secobarbital—GABRA2—brain—amyotrophic lateral sclerosis	0.000362	0.00563	CbGeAlD
Secobarbital—GABRA1—brain—amyotrophic lateral sclerosis	0.000349	0.00544	CbGeAlD
Secobarbital—CYP2C8—brain—amyotrophic lateral sclerosis	0.00023	0.00358	CbGeAlD
Secobarbital—GABRA5—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000194	0.00299	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000193	0.00297	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000193	0.00297	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00019	0.00294	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00019	0.00294	CbGpPWpGaD
Secobarbital—CHRNA4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000188	0.00291	CbGpPWpGaD
Secobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000187	0.00289	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000187	0.00289	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000187	0.00289	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000184	0.00284	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000183	0.00283	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000182	0.00281	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000181	0.0028	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000181	0.0028	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000181	0.00279	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00018	0.00279	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00018	0.00277	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000179	0.00276	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000179	0.00276	CbGpPWpGaD
Secobarbital—CHRNA7—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000177	0.00273	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000176	0.00272	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000176	0.00272	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000174	0.00269	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000173	0.00267	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000171	0.00264	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000169	0.00261	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000168	0.00259	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000167	0.00258	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000167	0.00258	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000167	0.00258	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000165	0.00256	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000165	0.00255	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000164	0.00253	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000164	0.00253	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000164	0.00253	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000163	0.00252	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000162	0.0025	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000162	0.0025	CbGpPWpGaD
Secobarbital—GABRA6—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000162	0.00249	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000161	0.00249	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000161	0.00249	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000161	0.00248	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00016	0.00246	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00016	0.00246	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00016	0.00246	CbGpPWpGaD
Secobarbital—GABRA4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00016	0.00246	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000159	0.00246	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000159	0.00246	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000159	0.00246	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000158	0.00244	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000156	0.00241	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000156	0.00241	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000155	0.0024	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000154	0.00238	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000153	0.00237	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000153	0.00237	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000153	0.00236	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000151	0.00234	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00015	0.00231	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00015	0.00231	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000149	0.00231	CbGpPWpGaD
Secobarbital—GRIA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000149	0.0023	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000148	0.00229	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000147	0.00228	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000147	0.00228	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000147	0.00226	CbGpPWpGaD
Secobarbital—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000146	0.00225	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000146	0.00225	CbGpPWpGaD
Secobarbital—CHRNA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000144	0.00223	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000143	0.00221	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000143	0.00221	CbGpPWpGaD
Secobarbital—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000142	0.00219	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000141	0.00217	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000141	0.00217	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00014	0.00216	CbGpPWpGaD
Secobarbital—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000139	0.00215	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000139	0.00214	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000139	0.00214	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000138	0.00214	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000137	0.00212	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000137	0.00212	CbGpPWpGaD
Secobarbital—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000137	0.00211	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000136	0.0021	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000135	0.00208	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000135	0.00208	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000135	0.00208	CbGpPWpGaD
Secobarbital—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000133	0.00206	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000133	0.00206	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000132	0.00204	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000131	0.00202	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000131	0.00202	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000131	0.00202	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000129	0.00199	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000126	0.00195	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000125	0.00194	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000125	0.00194	CbGpPWpGaD
Secobarbital—GABRA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000124	0.00191	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000123	0.00191	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000123	0.0019	CbGpPWpGaD
Secobarbital—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000122	0.00189	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000122	0.00189	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000122	0.00188	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000122	0.00188	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00012	0.00185	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00012	0.00185	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00012	0.00185	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000118	0.00182	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000118	0.00182	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000118	0.00182	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000117	0.00181	CbGpPWpGaD
Secobarbital—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000117	0.0018	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000115	0.00178	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000115	0.00177	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000115	0.00177	CbGpPWpGaD
Secobarbital—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000113	0.00174	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000113	0.00174	CbGpPWpGaD
Secobarbital—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000112	0.00173	CbGpPWpGaD
Secobarbital—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000109	0.00168	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000108	0.00167	CbGpPWpGaD
Secobarbital—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000107	0.00165	CbGpPWpGaD
Secobarbital—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000105	0.00162	CbGpPWpGaD
Secobarbital—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000102	0.00158	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000102	0.00158	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0001	0.00155	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0001	0.00155	CbGpPWpGaD
Secobarbital—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	9.98e-05	0.00154	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	9.84e-05	0.00152	CbGpPWpGaD
Secobarbital—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.18e-05	0.00142	CbGpPWpGaD
Secobarbital—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	8.94e-05	0.00138	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.78e-05	0.00136	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.67e-05	0.00134	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.31e-05	0.00128	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	8.26e-05	0.00128	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	8.17e-05	0.00126	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.93e-05	0.00122	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	7.86e-05	0.00121	CbGpPWpGaD
Secobarbital—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.84e-05	0.00121	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.7e-05	0.00119	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.57e-05	0.00117	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.47e-05	0.00115	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.47e-05	0.00115	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.43e-05	0.00115	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.37e-05	0.00114	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.37e-05	0.00114	CbGpPWpGaD
Secobarbital—GRIA2—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	7.33e-05	0.00113	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.25e-05	0.00112	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	7.19e-05	0.00111	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	7.1e-05	0.0011	CbGpPWpGaD
Secobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	6.94e-05	0.00107	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.74e-05	0.00104	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.74e-05	0.00104	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	6.68e-05	0.00103	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	6.66e-05	0.00103	CbGpPWpGaD
Secobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.66e-05	0.00103	CbGpPWpGaD
Secobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.57e-05	0.00101	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.55e-05	0.00101	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.55e-05	0.00101	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.43e-05	0.000993	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.43e-05	0.000993	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.4e-05	0.000988	CbGpPWpGaD
Secobarbital—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	6.36e-05	0.000982	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.34e-05	0.000979	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.32e-05	0.000976	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.32e-05	0.000976	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.28e-05	0.00097	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.17e-05	0.000952	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.17e-05	0.000952	CbGpPWpGaD
Secobarbital—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.01e-05	0.000928	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.85e-05	0.000903	CbGpPWpGaD
Secobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.84e-05	0.000902	CbGpPWpGaD
Secobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.73e-05	0.000885	CbGpPWpGaD
Secobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	5.66e-05	0.000873	CbGpPWpGaD
Secobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.63e-05	0.00087	CbGpPWpGaD
Secobarbital—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.5e-05	0.000849	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.47e-05	0.000844	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.44e-05	0.00084	CbGpPWpGaD
Secobarbital—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	5.43e-05	0.000839	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.39e-05	0.000832	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.39e-05	0.000832	CbGpPWpGaD
Secobarbital—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.18e-05	0.000799	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.11e-05	0.00079	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5e-05	0.000772	CbGpPWpGaD
Secobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.8e-05	0.000742	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	4.73e-05	0.00073	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.65e-05	0.000718	CbGpPWpGaD
Secobarbital—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.57e-05	0.000705	CbGpPWpGaD
Secobarbital—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.51e-05	0.000696	CbGpPWpGaD
Secobarbital—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.42e-05	0.000683	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.37e-05	0.000675	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.31e-05	0.000665	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	4.13e-05	0.000637	CbGpPWpGaD
Secobarbital—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.72e-05	0.000575	CbGpPWpGaD
Secobarbital—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.72e-05	0.000574	CbGpPWpGaD
Secobarbital—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.67e-05	0.000566	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.51e-05	0.000541	CbGpPWpGaD
Secobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	3.5e-05	0.000541	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	3.5e-05	0.00054	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	3.5e-05	0.00054	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.26e-05	0.000504	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	3.2e-05	0.000494	CbGpPWpGaD
Secobarbital—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.18e-05	0.000491	CbGpPWpGaD
Secobarbital—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.13e-05	0.000484	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3e-05	0.000462	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.98e-05	0.00046	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.85e-05	0.00044	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.85e-05	0.00044	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.8e-05	0.000432	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.66e-05	0.00041	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.61e-05	0.000402	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.53e-05	0.000391	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.43e-05	0.000376	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.43e-05	0.000376	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.42e-05	0.000374	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.28e-05	0.000352	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.27e-05	0.00035	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.23e-05	0.000344	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.07e-05	0.00032	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2.06e-05	0.000318	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.95e-05	0.000301	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.92e-05	0.000296	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.77e-05	0.000273	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.76e-05	0.000272	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.61e-05	0.000249	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.56e-05	0.000241	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.45e-05	0.000224	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.44e-05	0.000222	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.33e-05	0.000206	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.33e-05	0.000205	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.31e-05	0.000203	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.23e-05	0.00019	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.18e-05	0.000183	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.12e-05	0.000173	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.08e-05	0.000167	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.01e-05	0.000156	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.22e-06	0.000142	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.09e-06	0.00014	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.81e-06	0.000121	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.4e-06	0.000114	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.18e-06	0.000111	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.36e-06	9.82e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.32e-06	9.76e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	5.91e-06	9.12e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.84e-06	9.02e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.43e-06	8.39e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.99e-06	7.71e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.81e-06	7.42e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.11e-06	6.34e-05	CbGpPWpGaD
Secobarbital—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.05e-06	6.25e-05	CbGpPWpGaD
Secobarbital—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.29e-06	5.09e-05	CbGpPWpGaD
Secobarbital—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.81e-06	4.35e-05	CbGpPWpGaD
